Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla

Model for end-stage liver disease (MELD) and allocation of donor livers

Russell H. Wiesner, Erick Edwards, Richard B. Freeman et al. · Gastroenterology · 2003 · 2.5K citations · Full text

Medicine, Biostatistics, Hepatology +13

SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER

B Maharaj, W P Leary, A. D. Naran et al. · The Lancet · 1986 · 613 citations

Medicine, Pathology, Diagnostic Pathology +11

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Bernd Hamm, T Staks, Andreas Mühler et al. · Radiology · 1995 · 572 citations

Medicine, Pharmacokinetics, Radiology +17

Hepatogastroenterology

Lung‐Sheng Lu, Fu‐Chih Hung, Seng‐Kee Chuah et al. · Hepatogastroenterology · 2012 · 536 citations

Medicine, Molecular Biology, Oncology +17

Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid–enhanced MR Imaging—Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation

Takahiro Tsuboyama, Hiromitsu Onishi, Tonsok Kim et al. · Radiology · 2010 · 267 citations

Medicine, Oncology, Radiology +17